NVAX
Novavax, Inc.
-44.72%
$10.89 - $6.02
Feb 7th 2023 - Mar 21st 2023
OCGN
Ocugen Inc
-23.15%
$1.24 - $0.95
Feb 7th 2023 - Mar 21st 2023
positive
negative
Jan, 9, 2023
Once contracts are announced and a revenue is gene... See more
Oct, 26, 2022
$OCGN Let’s see TT completion and plans to begin c... See more
BLUE
Bluebird bio Inc
-31.24%
$6.69 - $4.60
Feb 7th 2023 - Mar 21st 2023
positive
negative
Nov, 6, 2022
Overall the company should be profitable going forward, we have grant funding through 2023, private sector purchasing at premium pricing, contracts for over 500 million doses vaccines, and revenue from matrix-m (malaria vaccine) to name a few.
positive
negative
Jan, 9, 2023
Once contracts are announced and a revenue is generated the SP will rise and hold.
Oct, 26, 2022
$OCGN Let’s see TT completion and plans to begin contracts with the US for intranasal bringing us to $18 again 👌 Damn… talk about a helluva good day.